# Tetracycline-Derivatives for Treatment of Cerebral Arteriovenous Malformations and Aneurysms

> **NCT00243893** · PHASE1 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 26 (actual)

## Conditions studied

- Aneurysms
- Arteriovenous Malformations

## Interventions

- **DRUG:** minocycline
- **DRUG:** doxycycline

## Key facts

- **NCT ID:** NCT00243893
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2013-10-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00243893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00243893, "Tetracycline-Derivatives for Treatment of Cerebral Arteriovenous Malformations and Aneurysms". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00243893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*